ODI — Odi Pharma AB (publ) Balance Sheet
0.000.00%
Last trade - 00:00- SEK41.06m
- SEK35.70m
- SEK22.29m
Annual balance sheet for Odi Pharma AB (publ), fiscal year end - June 30th, SEK millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 20.5 | 14.6 | 7.37 | 6.49 | 2.64 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.176 | 0.932 | 1.09 | 0.813 | 8.98 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 20.8 | 16.9 | 10.5 | 8.18 | 12.2 |
| Net Property, Plant And Equipment | 0.02 | 0.012 | 0.012 | 0.009 | 0.006 |
| Other Long Term Assets | |||||
| Total Assets | 20.9 | 16.9 | 10.5 | 8.19 | 12.2 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.786 | 0.582 | 1.24 | 5.61 | 10.2 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.786 | 0.582 | 1.24 | 5.61 | 10.2 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 20.1 | 16.3 | 9.26 | 2.57 | 2 |
| Total Liabilities & Shareholders' Equity | 20.9 | 16.9 | 10.5 | 8.19 | 12.2 |
| Total Common Shares Outstanding |